PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS

PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS

Despite the unprecedented success in using immune checkpoint inhibitors in the treatment of lung cancer, melanoma, hypermutable tumors of various localization, etc., a significant proportion of patients receiving these drugs do not respond to treatment. Predictive markers routinely used in the selec...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Janus, A. G. Ievleva, E. N. Suspitsyn, V. I. Tyurin, I. V. Bizin, O. A. Gorustovich, V. I. Ni, M. M. Kholmatov, T. A. Laidus, S. A. Chuynyshena, S. N. Aleksakhina, E. N. Imyanitov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2020-09-01
Series:Сибирский онкологический журнал
Subjects:
adenocarcinoma
predictive markers
immune response checkpoint inhibitors
pd-l1
pd1
ctla4
Online Access:https://www.siboncoj.ru/jour/article/view/1538
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.siboncoj.ru/jour/article/view/1538

Similar Items